Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Mitochondrial reactive oxygen species are essential for skin and hair development.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

ERULUS controls root hair growth by regulating cell wall composition and pectin activity.

A surface with VEGF can specifically capture endothelial cells from flowing fluids.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Early diagnosis and a strict gluten-free diet are crucial for children with celiac disease to improve symptoms.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Keratin-associated proteins are part of the developing hair fiber cuticle.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Enzymes called PADIs play a key role in hair growth and loss.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

VKHD and sarcoidosis may share a common cause.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Choosing the right method to separate skin layers is key for good skin cell research.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Peptide hydrogels show promise for healing skin, bone, and nerves but need improvement in stability and compatibility.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Ptprq has multiple forms that change during inner ear development.

Certain proteins are essential for the growth of root hairs in barley.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Most people with scarring and nonscarring hair loss show similar D2-40 levels, but some with scarring hair loss have higher levels.